F S&P 500
4,970.50 -78.50 (-1.55%) F Dow Jones
37,510.00 -497.00 (-1.31%) F Nasdaq
17,213.75 -333.50 (-1.90%) E-mini Russell 2000 Index Futur
1,918.60 -39.50 (-2.02%) Petróleo
85.78 +3.05 (+3.69%) Oro
2,425.30 +27.30 (+1.14%)
Inogen, Inc. (INGN)
Fuera de horario:
Inogen, Inc.
859 Ward Drive
Goleta, CA 93111
United States
805 562 0500
https://www.inogen.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 834
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Jason Somer | Executive VP, General Counsel & Corporate Secretary | 409.92k | N/D | 1968 |
| Dr. Stanislav Glezer M.D., MBA | Executive VP of R&D and Chief Medical Officer | 575.8k | N/D | 1973 |
| Mr. Kevin R. M. Smith | President, CEO & Director | N/D | N/D | 1971 |
| Mr. Michael J. Bourque | Executive VP, CFO & Treasurer | N/D | N/D | 1963 |
| Mr. Philip Corrin | Senior Vice President of Operations & Supply Chain | N/D | N/D | N/D |
| Ms. Jennifer Yi Boyer | Executive VP & Chief Human Resources Officer | N/D | N/D | N/D |
| Mr. Vijay Paliwal | Senior Vice President of Enterprise Enablement | N/D | N/D | N/D |
| Mr. Grgoire Ramade | Executive VP & Chief Commercial Officer | N/D | N/D | 1970 |
Descripción
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Inogen, Inc. a partir del 1 de abril de 2024 es 5. Las puntuaciones principales son Auditoría: 2; Junta: 5; Derechos del accionista: 8; Compensación: 6.
